Trial intelligence / Profile preview

Prospective study of remimazolam-assisted sedation and amnesia before general anesthesia

ChiCTR2400084233Phase 4Not yet recruiting

Sponsor
First Affiliated Hospital of Soochow University
Start
May 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in amnesia (3 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Extent of amnesia with different doses of remimazolam tosylate. Planned start May 2024; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

amnesia

Beyond the preview

Go deeper on ChiCTR2400084233.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400084233.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call